By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Atlas Bio leaves stealth with $12.5M to test drugs on simulated patients
    By
    msadmin
    October 27, 2026
    Practo’s founder banks $15M to screen healthy Indians for hidden disease
    By
    msadmin
    October 27, 2026
    Heartflow hauls a second rival into court over cardiac CT software
    By
    msadmin
    October 27, 2026
    Coreline Soft adds aortic measurements to its chest CT platform
    By
    msadmin
    October 27, 2026
    A self-taught model rebuilds blood flow maps from paediatric heart scans
    By
    msadmin
    October 27, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Deutsche Telekom’s venture arm buys into Tandem Health’s clinical assistant

T.Capital joined the Swedish company's Series B, betting on an AI documentation tool already live in more than 10,000 European care facilities.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: October 27, 2026
Share
2 Min Read
SHARE

Deutsche Telekom’s investment vehicle has bought into Tandem Health, the Stockholm company behind an AI medical assistant, as a participant in its Series B. T.Capital signed the check; the sum was not disclosed.

Contents
One billion hoursWhy documentation is the wedge

Tandem’s product pulls clinical documentation, billing codes and decision support into one platform. Its reach is already wide: more than 10,000 sites in 14 countries, Germany among them, links to roughly 130 record systems, and Class IIa certification under the EU Medical Device Regulation.

The rationale for the telecoms group is strategic as much as financial. Deutsche Telekom and its IT unit T-Systems are hunting share in digital health, and a certified tool with a wide installed base offers a way in.

One billion hours

Lukas Saari, Tandem’s co-founder and chief executive, puts the ambition in labour terms. He said that the aim was to hand Europe’s clinicians a billion hours back, so that doctors and nursing staff spend less of their day on paperwork and more of it with patients.

Karine Peters, a managing director at T.Capital, said the fund came in because the product trims administrative work while still clearing quality, safety and compliance bars. She added that the team looked capable of building tools that measurably help clinicians continent-wide, which made backing that ambition strategically appealing.

Why documentation is the wedge

Hospitals on the continent are squeezed by staffing shortages, mounting documentation duties and shrunken budgets. Ambient scribing became healthcare’s fastest-selling AI category for one reason: it attacks paperwork without asking a clinician to let a model near a diagnosis.

Gottfried Ludewig of T-Systems argued the sector needs trustworthy tools it can switch on straight away without surrendering data privacy or patient safety.

German market access is likely central. Tandem already operates there, and Telekom’s corporate ties could hurry hospital rollouts along.

TAGGED:AI scribesClinical AIDeutsche Telekomdigital health fundingEuropean health techTandem Health
SOURCES:Deutsche Telekom
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Google SymptomAI outperforms doctors in real-world symptom interviews

By
msadmin
July 27, 2026
News & Alerts

Personalized mRNA vaccine clears first phase 3 hurdle in melanoma

By
msadmin
August 19, 2026
News & Alerts

Scarlet lands $50M to certify AI medical devices faster

By
msadmin
October 13, 2026
News & Alerts

Explainable AI model ConceptCLIP shows clinicians its reasoning

By
msadmin
August 19, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal